Blepharokeratoconjunctivitis in childhood: Corneal involvement and visual outcome

Eye (Basingstoke)

Volumn 30, Issue 3, 2016, Pages 438-446

  Rodriguez Garcia A ^a,b   Gonzalez Godinez S ^a   Lopez Rubio S ^a  

^a ESCUELA DE MEDICINA Y CIENCIAS DE LA SALUD   (Mexico)

^b HOSPITAL ZAMBRANO HELLION   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLEPHAROKERATOCONJUNCTIVITIS; CASE CONTROL STUDY; CHILD; CHILDHOOD DISEASE; CORNEA PERFORATION; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HORDEOLUM; HUMAN; KERATOCONJUNCTIVITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PHOTOPHOBIA; PREVALENCE; PUNCTATE KERATITIS; RETROSPECTIVE STUDY; RISK FACTOR; VISION; VISUAL ACUITY; BLEPHARITIS; CHRONIC DISEASE; CORNEAL DISEASES; MEXICO; PATHOPHYSIOLOGY; PHYSIOLOGY;

BLEPHARITIS; CASE-CONTROL STUDIES; CHILD; CHRONIC DISEASE; CORNEAL DISEASES; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KERATOCONJUNCTIVITIS; MALE; MEXICO; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; VISUAL ACUITY;

EID: 85014579083     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2015.249     Document Type: Article

References (39)

1. Gupta N, Dhawan A, Beri S, D'souza P. Clinical spectrum of pediatric blepharokeratoconjunctivitis. J AAPOS 2010; 14: 527-529.
2. Hammersmith KM, Cohen EJ, Blake TD, Laibson PR, Rapuano CJ. Blepharokeratoconjunctivitis in children. Arch Ophthalmol 2005; 123: 1667-1670.
3. Farpour B, McClellan KA. Diagnosis and management of chronic blepharokeratoconjunctivitis in children. J Pediatr Ophthalmol Strabismus 2001; 38: 207-212.
4. Viswalingam M, Rauz S, Morlet N, Dart JK. Blepharokeratoconjunctivitis in children: diagnosis and treatment. Br J Ophthalmol 2005; 89: 400-403.
5. Doan S, Gabison EE, Nghiem-Buffet S, Abitbol O, Gatinel D, Hoang-Xuan T. Long-term visual outcome of childhood blepharokeratoconjunctivitis. Am J Ophthalmol 2007; 143: 528-529.
6. Mondino BJ, Adamu SA, Pitchenkian-Halabi H. Antibody studies in a rabbit model of corneal phlyctenulosis and catarrhal infiltrates related to Staphylococcus aureus. Invest Ophthalmol Vis Sci 1991; 32: 1854-1863.
7. Ficker L, Seal D, Wright P. Staphylococcal infection and the limbus: study of the cell-mediated immune response. Eye 1989; 3: 190-193.
8. Kumar A, Zhang J, Yu FS. Innate immune response of corneal epithelial cells to Staphylococcus aureus infection: Role of peptidoglycan in stimulating proinflammatory cytokine secretion. Invest Ophthalmol Vis Sci 2004; 45: 3513-3522.
9. Smolin G, Okumoto M. Staphylococcal blepharitis. Arch Ophthalmol 1977; 95: 812-816.
10. Jones SM, Weinstein JM, Cumberland P, Klein N, Nischal KK. Visual outcome and corneal changes in children with chronic blepharokeratoconjunctivitis. Ophthalmology 2007; 114: 2271-2280.
11. Teo L, Mehta JS, Htoon HM, Tan DTH. Severity of pediatric blepharokeratoconjunctivitis in Asian eyes. Am J Ophthalmol 2012; 153: 564-570.
12. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005; 140: 509-516.
13. West S, Williams C. Amblyopia. BMJ Clinical Evidence 2011; 2011: 0709.
14. Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O'Brien T et al. The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Management and Treatment of Meibomian Gland Dysfunction. Invest Ophthalmol Vis Sci 2011; 52: 2050-2064.
15. Cetinkaya A, Akova YA. Pediatric ocular acne rosacea: Long-term treatment with systemic antibiotics. Am J Ophthalmol 2006; 142: 816-821.
16. Hamada S, Kahn I, Denniston AK, Rauz S. Childhood blepharokeratoconjunctivitis: characterizing a severe phenotype in white adolescents. Br J Ophthalmol 2012; 96: 949-955.
17. Nazir SA, Murphy S, Siatkowski RM, Chodosh J, Siatkowski RL. Ocular rosacea in childhood. Am J Ophthalmol 2004; 137: 138-144.
18. Erzurum SA, Feder RS, Greenwald MJ. Acne rosacea with keratitis in childhood. Arch Ophthalmol 1993; 111: 228-230.
19. Nagymihalyi A, Dikstein S, Tiffany JM. The influence of eyelid temperature on the delivery of meibomian oil. Exp Eye Res 2004; 78: 367-370.
20. Olson MC, Korb DR, Greiner JV. Increase in tear film lipid layer thickness following treatment with warm compresses in patients with meibomian gland dysfunction. Eye Contact Lens 2003; 29: 96-99.
21. Goto E, Endo K, Suzuki A, Fujikura Y, Tsubota K. Improvement of tear stability following warm compression in patients with meibomian gland dysfunction. Adv Exp Med Biol 2002; 506: 1149-1152.
22. Macsai MS. The role of Omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction. (An AOS thesis). Trans Am Ophthalmol Soc 2008; 106: 336-356.
23. Pinna A, Piccinini P, Carta F. Effect of oral linoleic and gamma-linolenic acid on meibomian gland dysfunction. Cornea 2007; 26: 260-264.
24. Sullivan BD, Cermak JM, Sullivan RM, Papas AS, Evans JE, Dana MR et al. Correlations between nutrient intake and the polar lipid profiles of meibomian gland secretions in women with Sjogren's syndrome. Adv Exp Med Biol 2002; 506: 441-447.
25. Oleñik A, Jiménez-Alfaro I, Alejandre-Alba A, Mahillo-Fernández I. A randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunction. Clin Interv Aging 2013; 8: 1133-1138.
26. Wojtowicz JC, Butovich I, Uchiyama E, Aronowicz J, Agee S, McCulley JP. Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye. Cornea 2011; 30: 308-314.
27. Creuzot C, Passemard M, Viau S, Joffre C, Pouliquen P, Elena PP et al. Improvement of dry eye symptoms with polyunsaturated fatty acids. J Fr Ophtalmol 2006; 29: 868-873.
28. Lindsley K, Matsumura S, Hatef E, Akpek EK. Interventions for chronic blepharitis. Cochrane Database Syst Rev 2012; 5: CD005556.
29. Miljanovic B, Trivedi KA, Dana MR, Gilbard JP, Buring JE, Schaumberg DA. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr 2005; 82: 887-893.
30. Ambrosio Jr RJ, Stelzner SK, Boerner CF. Nutrition and dry eye: the role of lipids. Rev Refract Surg 2002; 1: 29-32.
31. Rand AL, Asbell PA. Nutritional supplements for dry eye syndrome. Curr Opin Ophthalmol 2011; 22: 279-282.
32. Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006; 83(6 Suppl) 1505S-1519S.
33. Erdinest N, Shmueli O, Grossman Y, Ovadia H, Solomon A. Anti-inflammatory effects of alpha linolenic acid on human corneal epithelial cells. Invest Ophthalmol Vis Sci 2012; 53: 4396-4406.
34. Lewis RA, Lee TH, Austen KF. Effects of Omega-3 Fatty Acids on the Generation of Products of the 5-lipoxygenase Pathway. Academic Press: Orlando, FL, USA, 1986.
35. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JWMet al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320: 265-271.
36. American Academy of Ophthalmology Cornea/External Disease Panel Preferred Practice Pattern Guidelines. Blepharitis. American Academy of Ophthalmology: San Francisco, CA, USA, 2013. Available at https://www.aao.org/ppp (accessed on 18 September 2015).
37. Auw-Hädrich C, Reinhard T. [Treatment of chronic blepharokeratoconjunctivitis with local calcineurin inhibitors]. Ophthalmologe 2009; 106: 635-638.
38. Rubin M, Rao SN. Efficacy of topical cyclosporin 0.05% in the treatment of posterior blepharitis. J Ocul Pharmacol Ther 2006; 22: 47-53.
39. Meisler DM, Raizman MB, Traboulsi EI. Oral erythromycin treatment for childhood blepharokeratitis. J AAPOS 2000; 4: 379-380.